ASX - By Stock
|
NEU |
Re:
$4 Target
|
|
SouthernAccent
|
129 |
42K |
0 |
15/06/23 |
15/06/23 |
ASX - By Stock
|
129
|
42K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
$4 Target
|
|
SouthernAccent
|
129 |
42K |
8 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
129
|
42K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
PYC turns 2 corners
|
|
SouthernAccent
|
44 |
18K |
0 |
04/06/23 |
04/06/23 |
ASX - By Stock
|
44
|
18K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
SouthernAccent
|
743 |
346K |
10 |
04/06/23 |
04/06/23 |
ASX - By Stock
|
743
|
346K
|
10
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
SouthernAccent
|
34 |
11K |
1 |
04/06/23 |
04/06/23 |
ASX - By Stock
|
34
|
11K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: A$80 million fully underwritten equity raising
|
|
SouthernAccent
|
57 |
26K |
4 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
57
|
26K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia CEO participates in White House Cancer Moonshot Forum
|
|
SouthernAccent
|
7 |
2.2K |
7 |
28/05/23 |
28/05/23 |
ASX - By Stock
|
7
|
2.2K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
High Quality Research-Non Cancer Disease
|
|
SouthernAccent
|
34 |
11K |
5 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
34
|
11K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Excellent initial Overall Survival Benefit in 1st line NSCLC
|
|
SouthernAccent
|
27 |
16K |
3 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
27
|
16K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Excellent initial Overall Survival Benefit in 1st line NSCLC
|
|
SouthernAccent
|
27 |
16K |
6 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
27
|
16K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Executive Leadership changes - Dr John Friend appointed CEO
|
|
SouthernAccent
|
55 |
18K |
5 |
03/05/23 |
03/05/23 |
ASX - By Stock
|
55
|
18K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.8K |
1.2M |
4 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presents new data at AACR Annual Meeting
|
|
SouthernAccent
|
36 |
15K |
3 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
36
|
15K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Shorting the sucker-rally
|
|
SouthernAccent
|
342 |
122K |
3 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
342
|
122K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Shorting the sucker-rally
|
|
SouthernAccent
|
342 |
122K |
14 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
342
|
122K
|
14
|
|
ASX - By Stock
|
MRM |
Re:
Ann: Euroz Hartleys Institutional Conference - Presentation
|
|
SouthernAccent
|
5 |
3.3K |
1 |
12/03/23 |
12/03/23 |
ASX - By Stock
|
5
|
3.3K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
FDA Approved
|
|
SouthernAccent
|
25 |
9.9K |
24 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
25
|
9.9K
|
24
|
|
ASX - By Stock
|
PAB |
Re:
Seagen............Pfizer/Merck deal in the US.
|
|
SouthernAccent
|
22 |
10K |
0 |
04/03/23 |
04/03/23 |
ASX - By Stock
|
22
|
10K
|
0
|
|
ASX - By Stock
|
PAB |
Seagen............Pfizer/Merck deal in the US.
|
|
SouthernAccent
|
22 |
10K |
9 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
22
|
10K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.8K |
1.2M |
14 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
14
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia Share Purchase Plan
|
|
SouthernAccent
|
31 |
9.9K |
9 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
31
|
9.9K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.8K |
1.2M |
17 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
17
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
SouthernAccent
|
11 |
4.7K |
2 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
11
|
4.7K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
SouthernAccent
|
11 |
4.7K |
4 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
11
|
4.7K
|
4
|
|
ASX - By Stock
|
PAB |
Re:
PAB Chart & TA
|
|
SouthernAccent
|
348 |
132K |
9 |
06/01/23 |
06/01/23 |
ASX - By Stock
|
348
|
132K
|
9
|
|
Charts
|
NEU |
Re:
ASX 200 - March rebalance
|
|
SouthernAccent
|
54 |
29K |
11 |
06/01/23 |
06/01/23 |
Charts
|
54
|
29K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: INSIGHT-003 triple combination data presented at SITC 2022
|
|
SouthernAccent
|
42 |
21K |
5 |
13/11/22 |
13/11/22 |
ASX - By Stock
|
42
|
21K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
SouthernAccent
|
18 |
8.5K |
10 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
18
|
8.5K
|
10
|
|
ASX - By Stock
|
SLX Energy |
Re:
Nuclear Power Related Media Thread
|
|
SouthernAccent
|
5.4K |
2.3M |
0 |
01/10/22 |
01/10/22 |
ASX - By Stock
|
5.4K
|
2.3M
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Pharmaceuticals with Proactive at ASX Small and Mid-Cap Conference
|
|
SouthernAccent
|
78 |
40K |
20 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
78
|
40K
|
20
|
|
ASX - By Stock
|
TOY |
Re:
General discussion
|
|
SouthernAccent
|
20 |
7.2K |
0 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
20
|
7.2K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.8K |
1.2M |
11 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.8K |
1.2M |
12 |
04/09/22 |
04/09/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Science & medicine
|
|
SouthernAccent
|
15 |
10K |
17 |
04/09/22 |
04/09/22 |
ASX - By Stock
|
15
|
10K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.8K |
1.2M |
2 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: GBM Agile Update
|
|
SouthernAccent
|
178 |
65K |
3 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
178
|
65K
|
3
|
|
ASX - By Stock
|
TOY |
Re:
General discussion
|
|
SouthernAccent
|
20 |
7.2K |
4 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
20
|
7.2K
|
4
|
|
ASX - By Stock
|
BRK |
Re:
Banter and General Comments .. BRK
|
|
SouthernAccent
|
12K |
3.9M |
0 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
12K
|
3.9M
|
0
|
|
ASX - By Stock
|
PAB |
Re:
Ann: New Research Grant For Deoxymabs in Metastatic Breast Cancer
|
|
SouthernAccent
|
10 |
4.1K |
6 |
26/08/22 |
26/08/22 |
ASX - By Stock
|
10
|
4.1K
|
6
|
|
ASX - By Stock
|
OVT |
Re:
Ann: Appointment of Administrators
|
|
SouthernAccent
|
26 |
18K |
0 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
26
|
18K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.8K |
1.2M |
5 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
5
|
|
ASX - By Stock
|
KZA |
Re:
Its a dead duck
|
|
SouthernAccent
|
69 |
25K |
0 |
19/08/22 |
19/08/22 |
ASX - By Stock
|
69
|
25K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Interim data from MSKCC study
|
|
SouthernAccent
|
47 |
21K |
5 |
18/08/22 |
18/08/22 |
ASX - By Stock
|
47
|
21K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.8K |
1.2M |
10 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
10
|
|
ASX - By Stock
|
KZA |
Re:
Its a dead duck
|
|
SouthernAccent
|
69 |
25K |
5 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
69
|
25K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.8K |
1.2M |
12 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
SouthernAccent
|
2.8K |
1.2M |
9 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
9
|
|
ASX - By Stock
|
OVT |
Re:
Ann: Appointment of Administrators
|
|
SouthernAccent
|
26 |
18K |
0 |
14/08/22 |
14/08/22 |
ASX - By Stock
|
26
|
18K
|
0
|
|
ASX - By Stock
|
IBX |
Re:
JOURNEY to 50c plus
|
|
SouthernAccent
|
605 |
233K |
4 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
605
|
233K
|
4
|
|
ASX - By Stock
|
OVT |
Re:
Ann: Appointment of Administrators
|
|
SouthernAccent
|
26 |
18K |
1 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
26
|
18K
|
1
|
|